Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA, U7 small nuclear 18 pseudogene (RNU7-18P) is a genomic sequence in humans that resembles the functional U7 small nuclear RNA gene, but contains sequence features typical of reverse-transcribed pseudogenes and does not encode a functional RNA product[1][4]. Functional U7 snRNA is part of the U7 snRNP complex, which is essential for histone pre-mRNA processing by facilitating 3′ end cleavage, but the pseudogenes of U7 (including RNU7-18P) do not contribute to this process[2][3]. Multiple pseudogenes of U7 snRNA exist in humans and other mammals, are often detected by sequence homology, and may be annotated in genome resources, but have no known biological, disease, or therapeutic relevance[1][4]. This entry has no established role as a drug target or in disease biology, nor is it therapeutically actionable. Standard structured target data fields such as "interacting drugs", "mechanism of action", and "biomarkers" are not applicable to RNA pseudogenes like RNU7-18P.
None (no mechanism of action; not an active biomolecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 18 pseudogene (RNU7-18P).